| MolName | (5E)-3-cyclohexyl-5-[[9-methyl-2-(4-methylpiperazin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C24H29N5O2S2 |
| Smiles | CC(C1=NC(N2CCN(C)CC2)=C2/C=C(\C(N3C4CCCCC4)=O)/SC3=S)=CC=CN1C2=O |
| InChI | InChI=1S/C24H29N5O2S2/c1-16-7-6-10-28-20(16)25-21(27-13-11-26(2)12-14-27)18(22(28)30)15-19-23(31)29(24(32)33-19)17-8-4-3-5-9-17/h6-7,10,15,17H,3-5,8-9,11-14H2,1-2H3/b19-15+ |
| InChIK | HOVQWWWEIFPSIZ-XDJHFCHBSA-N |
| TotalMolweight | 483.659 |
| Molweight | 483.659 |
| MonoisotopicMass | 483.176265 |
| CLogP | 1.6056 |
| CLogS | -4.357 |
| H Acceptors | 7 |
| TotalSurfaceArea | 355.57 |
| Relative PSA | 0.27359 |
| PolarSurfaceArea | 116.85 |
| Druglikeness | 3.8138 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.45455 |
| Fragments | 1 |
| Non HAtoms | 33 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| Rotatable Bond | 3 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Sp3Atoms | 15 |
| Symmetricatoms | 4 |
| Amides | 2 |
| Amines | 1 |
| AlkylAmines | 1 |
| BasicNitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - (5E)-3-cyclohexyl-5-[[9-methyl-2-(4-methylpiperazin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5E)-3-cyclohexyl-5-[[9-methyl-2-(4-methylpiperazin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one